Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06451133 · ClinicalTrials.gov registry record · NA

Hemodynamic Management Following Acute Traumatic Spinal Cord Injury

A NA study of Spinal Cord Injuries, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
228
Enrollment target
1
Study location

NCT06451133: Recruiting NA study of Spinal Cord Injuries, sponsored by The University of Texas Health Science Center, Houston.

NCT06451133 is a NA study of Spinal Cord Injuries that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 228 participants, above the 60-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (280% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06451133, a NA study of Spinal Cord Injuries, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
228 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the effect of various hemodynamic management strategies on functional neurologic outcomes and non-neurologic adverse events in the first 5 days following acute spinal cord injury (SCI). The hemodynamic management strategies assessed include targeting a mean arterial blood pressure (MAP) goal of 85-90 mmHg, targeting a spinal cord perfusion pressure (SCPP) goal of ≥65 mmHg, or targeting normal hemodynamics, which is a MAP goal of ≥65 mmHg.

Primary Outcome

Upper and lower extremities will be assessed, and motor strength at each spinal cord level will be scored from 0 to 5 (0 indicates total paralysis and 5 indicates active movement against full resistance), with a maximum score of 25 for each extremity, totaling 100 for all four extremities. Total score ranges from 0 to 100, with a higher score indicating a better outcome.

Conditions Studied

Interventions

  • OTHER Mean arterial blood pressure (MAP) goal of ≥65 mmHg
  • OTHER Mean arterial blood pressure (MAP) goal of 85-90 mmHg
  • OTHER Spinal cord perfusion pressure (SCPP) goal of ≥65 mmHg

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 228 participants
Start Date 2024-07-03
Est. Completion 2026-07-31
Phase NA

What NCT06451133 shows while recruiting

NCT06451133 is an interventional study that assigns participants to a tested intervention. The registered 228 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (280% higher).

The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 3 interventions - of which Mean arterial blood pressure (MAP) goal of ≥65 mmHg is the first listed.

NCT06451133 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06451133 about?

NCT06451133 is a clinical study titled "Hemodynamic Management Following Acute Traumatic Spinal Cord Injury". The purpose of this study is to assess the effect of various hemodynamic management strategies on functional neurologic outcomes and non-neurologic adverse events in the first 5 days following acute spinal cord injury (SCI). The hemodynamic management strategies assessed include targeting a mean art...

What is the current status of trial NCT06451133?

This trial is currently recruiting. It is a NA study. The enrollment target is 228 participants. The study started on 2024-07-03. Estimated completion is 2026-07-31.

What conditions does trial NCT06451133 study?

This clinical trial studies the following conditions: Spinal Cord Injuries.

What interventions are being tested in trial NCT06451133?

The interventions under investigation include: Mean arterial blood pressure (MAP) goal of ≥65 mmHg (OTHER), Mean arterial blood pressure (MAP) goal of 85-90 mmHg (OTHER), Spinal cord perfusion pressure (SCPP) goal of ≥65 mmHg (OTHER).

Who is sponsoring clinical trial NCT06451133?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06451133 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06451133's enrollment target sits among peer trials

228 9th of 202 higher than 194 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05107908 · 228 participants · NA

    Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity

  • NCT05547698 · 228 participants · NA

    A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation

  • NCT05630963 · 228 participants

    Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression

  • NCT06073665 · 228 participants · Phase 4

    Dosing of LT4 in Older Individuals

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT06451133, the US trial registry maintained by the National Library of Medicine. NCT06451133 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.